A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance

Annals of the Rheumatic Diseases

Volumn 69, Issue 1, 2010, Pages 291-296

  Gossye, V ^a   Elewaut, D ^b   Van Beneden, K ^b   Dewint, P ^b   Haegeman, G ^a   De Bosscher, K ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HERBACEOUS AGENT; INTERLEUKIN 6; INTERLEUKIN 8; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RECEPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; EX VIVO STUDY; FIBROBLAST; GENE; GENE CONTROL; GENE REPRESSION; GLUCOCORTICOID RESPONSIVE ELEMENT; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR DOWN REGULATION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TRANSACTIVATION; WESTERN BLOTTING;

ACETATES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; DEXAMETHASONE; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE; ETHYLAMINES; GLUCOCORTICOIDS; INFLAMMATION MEDIATORS; LIGANDS; MALE; MICE; MICE, INBRED DBA; RECEPTORS, GLUCOCORTICOID;

EID: 73449098948     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.102871     Document Type: Article

References (27)

1. Hillier S. Diamonds are forever: the cortisone legacy. J Endocrinol 2007;195:1-6.
2. Rosen J, Miner JN. The search for safer glucocorticoid receptor ligands. Endocr Rev 2005;26:452-64.
3. SchäckeH, BergerM, Hansson TG, et al. Dissociated non-steroidal glucocorticoid receptor modulators: an update on new compounds. Expert Opin Ther Patents 2008;18:339-52.
4. Gossye V, Haegeman G, De Bosscher K. Therapeutic implications of the nuclear factor-kappa B/nuclear receptor cross-talk. Frontiers Biosci 2008;13:4122-43.
5. De Bosscher K, Vanden Berghe W, Haegeman G. Nuclear receptors and NF-kappaB Oncogene 2006;51:6868-86.
6. Louw A, Swart P, de Kock SS, van der Merwe KJ. Mechanism for the stabilization in vivo of the aziridine precursor - (4-acetoxyphenyl)-2-chloro- N-methyl-ethylammonium chloride by serum proteins. Biochem Pharmacol 1997;53:189-97.
7. De Bosscher K, Vanden Berghe W, Beck IM, et al. A fully dissociated compound of plant origin for inflammatory gene repression. Proc Natl Acad Sci U S A 2005;102:15827-32.
8. Dewint P, Gossye V, De Bosscher K, et al. A plant-derived ligand favoring monomeric glucocorticoid receptor conformation with impaired transactivation potential attenuates collagen-induced arthritis. J Immunol 2008;180:2608-15.
9. Sliwinska-Stanczyk P, Pazdur J, Ziolkowska M, et al. The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients. Scand J Rheumatol 2007;36:167-71.
10. Kirwan JR. Glucocorticoid resistance in patients with rheumatoid arthritis. Scand J Rheumatol 2007;36:165-6.
11. Kirwan J, Power L. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis. Curr Opin Rheumatol 2007;19:233-7.
12. Oakley RH, Cidlowski JA. Homologous down regulation of the glucocorticoid receptor: the molecular machinery. Crit Rev Eukaryot Gene Expr 1993;3:63-88.
13. Schaaf MJ, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002;83:37-48.
14. Buttgereit F, Saag KG, Cutolo M, et al. The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol 2005;34:14-21.
15. Meyer AS, Schmidt TJ. Differential effects of agonist and antagonists on autoregulation of glucocorticoid receptors in a rat colonic adenocarcinoma cell line. J Steroid Biochem Mol Biol 1997;62:97- 105.
16. Dong Y, Poellinger L, Gustafsson JA, Okret S. Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 1988;2:1256-64.
17. Bellingham DL, Sar M, Cidlowski JA. Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Mol Endocrinol 1992;6:2090-102.
18. Chikanza IC, Kozaci DL. Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives. Rheumatology (Oxford) 2004;43:1337-45.
19. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. De Bosscher K, Schmitz ML, Vanden Berghe W, et al. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 1997;94:13504-9.
21. BradfordMM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
22. Van den Berghe W, Francesconi E, De Bosscher K, et al. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism. Mol Pharmacol 1999;56:797-806.
23. Miyazawa K, Mori A, Yamamoto K, Okudaira H. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NFkappaB and CBF1. Am J Pathol 1998;152:793-803.
24. Loetscher P, Dewald B, Baggiolini M, Seitz M. Monocyte chemoattractant protein 1 and interleukin 8 production by rheumatoid synoviocytes. Cytokine 1994;6:162-70.
25. Sanden S, Tripmacher R, Weltrich R, et al. Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases. J Rheumatol 2000;27:1265-70.
26. Norman M, Hearing S. Glucocorticoid resistance - what is known? Curr Opin Pharmacol 2002;2:723-9.
27. Alarid ET. Lives and times of nuclear receptors. Mol Endocrinol 2006;20:1972-81.